Daily Intraperitoneal Administration of Rosiglitazone Does Not Improve Lung Function or Alveolarization in Preterm Rabbits Exposed to Hyperoxia
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details